Clinical Scorecard: Utilizing Chest CT Biomarkers for Identifying High-Risk COVID-19 Patients: Insights from a Retrospective Multicenter Analysis
At a Glance
Category
Detail
Condition
COVID-19 pneumonia and associated complications
Key Mechanisms
Chest CT biomarkers assess pneumonia extent, lung attenuation features, coronary artery calcium, bone density, and soft tissue fat infiltration to stratify risk
Target Population
Adult patients (≥18 years) with RT-PCR-confirmed SARS-CoV-2 infection undergoing chest CT within 72 hours of hospital admission
Care Setting
Tertiary-level hospitals, emergency departments during COVID-19 outbreak
Key Highlights
Chest CT provides superior sensitivity and differential diagnosis compared to chest X-ray in COVID-19 pneumonia.
Pneumonia extension and attenuation features on CT correlate with disease severity, oxygen impairment, and outcomes.
CT-derived cardiovascular and metabolic biomarkers (e.g., coronary calcium score, bone attenuation, myosteatosis) offer incremental prognostic value beyond clinical data.
Guideline-Based Recommendations
Diagnosis
Use chest CT to rapidly diagnose SARS-CoV-2 pneumonia, especially in overwhelmed EDs and community transmission settings.
Perform chest CT within 72 hours of admission for confirmed COVID-19 patients to assess lung involvement and complications.
Management
Incorporate CT pneumonia extension scores and attenuation features to stratify patient risk and guide oxygen therapy and ventilation decisions.
Evaluate coronary artery calcium score from non-contrast chest CT to identify patients at high cardiovascular risk.
Consider CT markers of bone density and soft tissue fat infiltration to assess patient fragility and comorbidities.
Monitoring & Follow-up
Monitor clinical and laboratory parameters alongside CT biomarkers for comprehensive risk assessment.
Use standardized CT protocols and centralized image analysis to ensure reproducibility and accuracy.
Risks
Avoid contrast-enhanced CT scans in this protocol to maintain consistency and comparability of calcium scoring.
Be aware of potential missing data in clinical predictors; CT biomarkers can help overcome some limitations.
Patient & Prescribing Data
Adult hospitalized COVID-19 patients undergoing chest CT within 72 hours of admission
CT biomarkers combined with clinical and laboratory data improve phenotyping of high-risk patients, potentially guiding timely interventions such as oxygen therapy and intubation.
Clinical Best Practices
Use a multiparametric chest CT approach including pneumonia extension scoring and cardiovascular/metabolic biomarkers for enhanced risk stratification.
by Anna Palmisano, Chiara Gnasso, Alberto Cereda, Davide Vignale, Riccardo Leone, Valeria Nicoletti, Simone Barbieri, Marco Toselli, Francesco Giannini, Marco Loffi, Gianluigi Patelli, Alberto Monello, Gianmarco Iannopollo, Davide Ippolito, Elisabetta Maria Mancini, Gianluca Pontone, Luigi Vignali, Elisa Scarnecchia, Mario Iannaccone, Lucio Baffoni, Massimiliano Spernadio, Caterina Chiara de Carlini, Sandro Sironi, Claudio Rapezzi, Antonio Esposito
